These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8230944)

  • 1. Orthotopic liver transplantation at KU Medical Center.
    Forster J; Delcore R
    Kans Med; 1993 Jul; 94(7):203-6. PubMed ID: 8230944
    [No Abstract]   [Full Text] [Related]  

  • 2. Adult liver transplantation: the Université Catholique de Louvain experience.
    Lerut J; Ciccarelli O; Roggen F; Laterre PF; Goffette P; Danse E; Reding R; Geubel A; Reynaert MS; Otte JB
    Clin Transpl; 2000; ():281-95. PubMed ID: 11512322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression in liver transplantation.
    Post DJ; Douglas DD; Mulligan DC
    Liver Transpl; 2005 Nov; 11(11):1307-14. PubMed ID: 16237688
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and pathological analysis of acute rejection following orthotopic liver transplantation.
    Ma Y; Wang GD; He XS; Li JL; Zhu XF; Hu RD
    Chin Med J (Engl); 2009 Jun; 122(12):1400-3. PubMed ID: 19567160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver transplantation. Indications, results, pre- and postoperative care].
    Böker KH; Oldhafer K
    Internist (Berl); 1996 Mar; 37(3):250-63. PubMed ID: 8919942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver transplantation for metabolic liver disease in adulthood].
    Rifai K; Manns MP; Bahr MJ
    Z Gastroenterol; 2004 Aug; 42(8):749-65. PubMed ID: 15314729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic management of postoperative biliary complications in orthotopic liver transplantation.
    Pfau PR; Kochman ML; Lewis JD; Long WB; Lucey MR; Olthoff K; Shaked A; Ginsberg GG
    Gastrointest Endosc; 2000 Jul; 52(1):55-63. PubMed ID: 10882963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms.
    Gomez-Camarero J; Salcedo M; Rincon D; Lo Iacono O; Ripoll C; Hernando A; Sanz C; Clemente G; Bañares R
    Transplantation; 2007 Sep; 84(6):786-91. PubMed ID: 17893613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation: the current situation.
    Adam R; Hoti E
    Semin Liver Dis; 2009 Feb; 29(1):3-18. PubMed ID: 19235656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte reduction during orthotopic liver transplantation and postoperative outcome: a pilot study.
    Parker BM; Irefin SA; Sabharwal V; Tetzlaff JE; Beven C; Younossi Z; Karafa MT; Vogt DP; Henderson JM
    J Clin Anesth; 2004 Feb; 16(1):18-24. PubMed ID: 14984855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation.
    Zaghla H; Selby RR; Chan LS; Kahn JA; Donovan JA; Jabbour N; Genyk Y; Mateo R; Gagandeep S; Sher LS; Ramicone E; Fong TL
    Aliment Pharmacol Ther; 2006 Feb; 23(4):513-20. PubMed ID: 16441472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction in hospital stay after liver transplantation.
    Harrison DM; Stewart AS; Koneru B; Holman MJ
    Transplant Proc; 1996 Apr; 28(2):896. PubMed ID: 8623451
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressant switching between cyclosporine and tacrolimus after liver transplantation.
    Hashikura Y; Kawasaki S; Matsunami H; Terada M; Ikegami T; Nakazawa Y; Watanabe M; Chisuwa H; Kamijima T; Takagi S; Makuuchi M
    Transplant Proc; 1996 Apr; 28(2):1034-5. PubMed ID: 8623218
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
    McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
    Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. University of Nebraska Medical Center Liver Transplant Program.
    Langnas AN; Fox IJ; Heffron TG; Zetterman RK; Donovan J; McCashlandT ; Dhawan A; Kaufman S; Sorrell MF; Shaw BW
    Clin Transpl; 1995; ():177-85. PubMed ID: 8794264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthotopic liver transplantation.
    Aune S
    Ann Chir Gynaecol Fenn; 1973; 62(4):175-7. PubMed ID: 4587702
    [No Abstract]   [Full Text] [Related]  

  • 20. Retinal complications in patients with solid organ or bone marrow transplantations.
    Chung H; Kim KH; Kim JG; Lee SY; Yoon YH
    Transplantation; 2007 Mar; 83(6):694-9. PubMed ID: 17414700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.